STOCK TITAN

Amgen (NASDAQ: AMGN) CEO records 5,057-share equity tax withholding

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AMGEN INC Chairman, CEO and President Robert A. Bradway reported routine equity-related activity in company stock. The filing shows tax-withholding dispositions totaling 5,057 shares of common stock at $329.82 per share, used to cover exercise price or tax liabilities tied to equity awards.

Bradway also reports indirect holdings in Amgen common stock through his spouse and related GRATs, alongside Dividend Equivalents credited to unvested Restricted Stock Units that pay out in shares as they vest. These transactions do not reflect open-market buying or selling decisions.

Positive

  • None.

Negative

  • None.
Insider Bradway Robert A
Role Chairman, CEO and President
Type Security Shares Price Value
Tax Withholding Common Stock 2,631 $329.82 $868K
Tax Withholding Common Stock 2,426 $329.82 $800K
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 499,231 shares (Direct, null); Common Stock — 60,060 shares (Indirect, By GRAT)
Footnotes (1)
  1. [object Object]
Tax-withholding shares total 5,057 shares Common stock delivered for tax obligations on equity awards
First tax-withholding block 2,426 shares at $329.82/share Non-derivative disposition code F on common stock
Second tax-withholding block 2,631 shares at $329.82/share Non-derivative disposition code F on common stock
Spousal indirect holding 29,940 shares Indirect ownership by spouse, common stock
Spousal GRAT holding 60,060 shares Indirect ownership by spousal GRAT, common stock
GRAT holding 60,060 shares Indirect ownership by GRAT, common stock
Dividend Equivalents in RSUs 1,624 DEs Credited to unvested RSUs, paid out in shares upon vesting
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Dividend Equivalents financial
"These shares include 1,624 Dividend Equivalents (DEs) granted pursuant"
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
Restricted Stock Units financial
"DEs are credited to the reporting person's unvested Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Grantor Retained Annuity Trust financial
"nature_of_ownership: By Spousal GRAT and By GRAT"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
indirect ownership financial
"direct_or_indirect: I, nature_of_ownership: By Spouse / By Spousal GRAT"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bradway Robert A

(Last)(First)(Middle)
ONE AMGEN CENTER DRIVE

(Street)
THOUSAND OAKS CALIFORNIA 91320-1799

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chairman, CEO and President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/02/2026F2,631D$329.82499,231D
Common Stock05/02/2026F2,426D$329.82496,805(1)D
Common Stock60,060IBy GRAT
Common Stock60,060IBy Spousal GRAT
Common Stock29,940IBy Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares include 1,624 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
/s/ Robert A. Bradway05/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did AMGN CEO Robert Bradway report?

Robert A. Bradway reported tax-withholding dispositions of Amgen common stock, not open-market trades. The Form 4 shows shares delivered back to the company to cover the exercise price or tax liabilities arising from equity awards, a routine compensation-related event.

How many Amgen (AMGN) shares were used for tax withholding?

The filing shows 5,057 shares of Amgen common stock used for tax-withholding purposes. These consisted of 2,426 shares and 2,631 shares, each recorded at $329.82 per share, reflecting shares delivered to satisfy obligations tied to equity compensation.

At what price were the Amgen shares valued for the CEO’s tax withholding?

Both tax-withholding dispositions were recorded at $329.82 per share. This price was applied to 2,426 shares and 2,631 shares of Amgen common stock, representing the value used when shares were delivered to cover exercise price or tax liabilities related to equity awards.

Does the Amgen Form 4 show open-market buying or selling by the CEO?

No, the Form 4 reflects tax-withholding dispositions, not open-market purchases or sales. Shares were delivered to pay exercise price or taxes arising from equity compensation. These transactions are mechanistic and do not indicate discretionary trading decisions in the open market.

What indirect Amgen (AMGN) holdings are reported for Robert Bradway?

The filing lists indirect ownership of Amgen common stock held by the CEO’s spouse and by spousal and other GRATs. These entries show ongoing positions associated with related entities, separate from his directly held shares, and are reported as indirect beneficial ownership.

What are Dividend Equivalents mentioned in the Amgen CEO’s Form 4?

Dividend Equivalents are DEs credited to unvested Restricted Stock Units under Amgen’s equity plan. They track dividends on the underlying stock and are paid out in shares of common stock on a one-to-one basis as the RSUs vest, plus cash for any fractional share amounts.